Experience and expertise have made Hugh E. Black & Associates leaders in preclinical drug safety and development consulting
. Established in 1994, led by Dr. Black’s senior management and staffed by a small nucleus of individuals with years of senior industrial and regulatory experience, Hugh E. Black & Associates has assisted clients in all aspects of preclinical research
, safety and metabolism. Our background and experience spans both industry and FDA regulatory process
, offering our clients the sound advice and assistance that results in successful development programs for new medicines or medical devices.